Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Retsas

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Anti-Cancer Drugs|February 1, 1996
Taxol and vinorelbine: a new active combination for disseminated malignant melanomaS Retsas, A Mohith, H Mackenzie
Die Pharmazie|June 1, 1990
Synthesis of 2-, 4- and 5-benzoylpyrrole-3-acetic acids and study of their in vitro effects on active oxygen speciesV J Demopoulos, E Rekka, S Retsas
Anticancer Research|January 1, 1993
Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II studyA J Stanley, R Kaprielian, S Retsas
Lancet (London, England)|July 23, 1994
Pharmaceuticals from plantsS Retsas, A Photiou, S J Jackson
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Alpha-interferons: impact on survival of patients with renal cell carcinomaS Retsas, D Bafaloukos, A M Brunt
Clinical Oncology|March 1, 1981
The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanomaS Retsas, C Thomas, J R Hobbs
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine as a single agent in the treatment of advanced malignant melanomaS Retsas, K A Newton, G Westbury
Journal of the Royal Society of Medicine|September 1, 1985
Malignant melanoma: prolonged survival after cerebral metastasisB E Monk, A du Vivier, S Retsas
Melanoma Research|December 3, 2002
The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancersJ P Alao, M Q Mohammed, S Retsas
British Medical Journal|June 4, 1977
Symptom relief with levamisole in stage IV Hodgkin's diseaseR H Phillips, S Retsas, K A Newton
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Anti-Cancer Drugs|February 1, 1996
Taxol and vinorelbine: a new active combination for disseminated malignant melanomaS Retsas, A Mohith, H Mackenzie
Die Pharmazie|June 1, 1990
Synthesis of 2-, 4- and 5-benzoylpyrrole-3-acetic acids and study of their in vitro effects on active oxygen speciesV J Demopoulos, E Rekka, S Retsas
Anticancer Research|January 1, 1993
Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II studyA J Stanley, R Kaprielian, S Retsas
Lancet (London, England)|July 23, 1994
Pharmaceuticals from plantsS Retsas, A Photiou, S J Jackson
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Alpha-interferons: impact on survival of patients with renal cell carcinomaS Retsas, D Bafaloukos, A M Brunt
Clinical Oncology|March 1, 1981
The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanomaS Retsas, C Thomas, J R Hobbs
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine as a single agent in the treatment of advanced malignant melanomaS Retsas, K A Newton, G Westbury
Journal of the Royal Society of Medicine|September 1, 1985
Malignant melanoma: prolonged survival after cerebral metastasisB E Monk, A du Vivier, S Retsas
Melanoma Research|December 3, 2002
The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancersJ P Alao, M Q Mohammed, S Retsas
British Medical Journal|June 4, 1977
Symptom relief with levamisole in stage IV Hodgkin's diseaseR H Phillips, S Retsas, K A Newton
Pageof 7